Trial intelligence / Profile preview

Zofenopril calcium plus amlodipine versus monotherapy in grade 1-2 hypertension

2021-000745-40Phase 4Completed

Sponsor
Menarini Group
Start
Sep 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of zofenopril and amlodipine in hypertension (HTN) (3 arms), sponsored by Menarini Group. Primary endpoint: Change in mean sitting diastolic blood pressure. Started Sep 2021; status: completed.

02

Drugs

zofenoprilamlodipine
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on 2021-000745-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-000745-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call